Genome-wide analysis of hepatic lipid content in extreme obesity-Reference-Cited by-同舟云学术

Genome-wide analysis of hepatic lipid content in extreme obesity

Published:2014-09-23 Issue:2 Volume:52 Page:373-382
ISSN:0940-5429
Container-title:Acta Diabetologica
language:en
Short-container-title:Acta Diabetol

Author:

DiStefano Johanna K.,Kingsley Christopher,Craig Wood G.,Chu Xin,Argyropoulos George,Still Christopher D.,Doné Stefania Cotta,Legendre Christophe,Tembe Waibhav,Gerhard Glenn S.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00592-014-0654-3.pdf

Reference50 articles.

1. Wang Y, Li YY, Nie YQ, Zhou YJ, Cao CY, Xu L (2013) Association between metabolic syndrome and the development of non-alcoholic fatty liver disease. Exp Ther Med 6:77–84

2. Fabbrini E, Sullivan S, Klein S (2010) Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51:679–689

3. Birkenfeld AL, Shulman GI (2014) Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology 59:713–723

4. Day CP (2006) Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease. Liver Int Off J Int Assoc Study Liver 26:1021–1028

5. Machado M, Marques-Vidal P, Cortez-Pinto H (2006) Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol 45:600–606

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-induced cis-regulatory elements in human hepatocytes affect molecular phenotypes associated with adverse reactions;2024-07-24

2. Integrating single-cell and bulk sequencing data to identify glycosylation-based genes in non-alcoholic fatty liver disease-associated hepatocellular carcinoma;PeerJ;2024-03-18

3. Unraveling the pathogenesis of non‐alcoholic fatty liver diseases through genome‐wide association studies;Journal of Gastroenterology and Hepatology;2023-08-17

4. Genetics and epigenetics in the obesity phenotyping scenario;Reviews in Endocrine and Metabolic Disorders;2023-04-10

5. Genome Editing and Fatty Liver;Advances in Experimental Medicine and Biology;2022-12-02